首页 > 最新文献

Pain Practice最新文献

英文 中文
How do people with chronic low back pain perceive specific and general exercise? A mixed methods survey. 慢性腰背痛患者如何看待特定运动和一般运动?混合方法调查。
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-01 Epub Date: 2024-02-20 DOI: 10.1111/papr.13354
A Natoli, M D Jones, V Long, B Mouatt, E D Walker, M T Gibbs

Purpose: Exercise prescriptions for chronic low back pain (CLBP) often utilize reductionistic, trunk-focused exercise aimed at addressing proposed pain mechanisms. It is unknown if the use of these trunk-focused exercises imply beliefs to people with CLBP about the rationale for their use (e.g., etiology), even without concurrent biomedical narratives. This study aimed to explore people's perceptions of specific and general exercise without an accompanying narrative when experiencing CLBP.

Methods: An anonymous online survey was distributed. Mixed methods were utilized for analysis. Six-point Likert scales categorized people's beliefs about individual exercises. Open-ended questions were used to gather further beliefs which were then coded into themes.

Results: People with CLBP perceived specific exercise as more beneficial than general exercise. Eight themes and five subthemes were defined. A high volume of positive beliefs were centered around strengthening the low back and abdominal musculature, emphasizing the importance of correct technique. Negative beliefs were held against spinal flexion and external load. Both positive and negative beliefs were underpinned by spinal/pelvic stability being important as well as certain exercises being achievable or not.

Conclusion: This study demonstrated that people with CLBP consider specific exercises to be more beneficial than general exercises for CLBP. Specific exercises irrespective of an accompanying narrative can imply meaning about the intent of an exercise. Understanding this requires practitioners to be mindful when prescribing and communicating exercise.

目的:针对慢性腰背痛(CLBP)的运动处方通常采用简化的、以躯干为重点的运动,旨在解决所提出的疼痛机制。目前尚不清楚使用这些以躯干为重点的运动是否意味着慢性腰背痛患者对其使用理由(如病因学)的信念,即使没有同时进行的生物医学叙述也是如此。本研究旨在探讨在没有相关叙述的情况下,CLBP 患者对特定运动和一般运动的看法:方法:发放匿名在线调查问卷。采用混合方法进行分析。六点李克特量表对人们对个别运动的看法进行了分类。使用开放式问题收集更多信念,然后将其编码为主题:结果:CLBP 患者认为特定运动比一般运动更有益。确定了八个主题和五个次主题。大量积极信念都围绕着增强腰部和腹部肌肉组织,强调正确技巧的重要性。消极信念则针对脊柱弯曲和外部负荷。脊柱/骨盆稳定性的重要性以及某些练习是否可以实现都是积极和消极信念的基础:本研究表明,慢性脊柱炎患者认为针对慢性脊柱炎的特定运动比一般运动更有益。无论是否有附带的说明,特定运动都会暗示运动的意图。要理解这一点,从业人员在开具运动处方和传达运动信息时就必须注意这一点。
{"title":"How do people with chronic low back pain perceive specific and general exercise? A mixed methods survey.","authors":"A Natoli, M D Jones, V Long, B Mouatt, E D Walker, M T Gibbs","doi":"10.1111/papr.13354","DOIUrl":"10.1111/papr.13354","url":null,"abstract":"<p><strong>Purpose: </strong>Exercise prescriptions for chronic low back pain (CLBP) often utilize reductionistic, trunk-focused exercise aimed at addressing proposed pain mechanisms. It is unknown if the use of these trunk-focused exercises imply beliefs to people with CLBP about the rationale for their use (e.g., etiology), even without concurrent biomedical narratives. This study aimed to explore people's perceptions of specific and general exercise without an accompanying narrative when experiencing CLBP.</p><p><strong>Methods: </strong>An anonymous online survey was distributed. Mixed methods were utilized for analysis. Six-point Likert scales categorized people's beliefs about individual exercises. Open-ended questions were used to gather further beliefs which were then coded into themes.</p><p><strong>Results: </strong>People with CLBP perceived specific exercise as more beneficial than general exercise. Eight themes and five subthemes were defined. A high volume of positive beliefs were centered around strengthening the low back and abdominal musculature, emphasizing the importance of correct technique. Negative beliefs were held against spinal flexion and external load. Both positive and negative beliefs were underpinned by spinal/pelvic stability being important as well as certain exercises being achievable or not.</p><p><strong>Conclusion: </strong>This study demonstrated that people with CLBP consider specific exercises to be more beneficial than general exercises for CLBP. Specific exercises irrespective of an accompanying narrative can imply meaning about the intent of an exercise. Understanding this requires practitioners to be mindful when prescribing and communicating exercise.</p>","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":" ","pages":"739-748"},"PeriodicalIF":2.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139913191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spinal cord stimulation for the symptomatic treatment of rigidity and painful spasm in a case of stiff person syndrome. 脊髓刺激治疗僵直综合征病例中的僵直和疼痛性痉挛。
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-01 Epub Date: 2024-01-07 DOI: 10.1111/papr.13340
Janus Patel, Emily Deschler, Enrique Galang

Background: Stiff person syndrome (SPS) is a rare neuroimmunological disorder characterized by rigidity and painful spasm primarily affecting the truncal and paraspinal musculature due to autoimmune-mediated neuronal hyperexcitability. Spinal cord stimulation (SCS) is an approved therapy for managing painful neuropathic conditions, including diabetic peripheral neuropathy and refractory angina pectoris. We describe the novel use of SCS for the treatment of spasm and rigidity in a 49-year-old man with seropositive stiff person syndrome (SPS). The patient was treated with intravenous immunoglobulin (IVIG) and oral medications over a 13-month period with minimal improvement, prompting consideration of SCS. To our knowledge, this is the first report of the successful use of SCS in SPS with the demonstration of multifaceted clinical improvement.

Methods: Following a successful temporary SCS trial, permanent implantation was performed. Spasm/stiffness (Distribution of Stiffness Index; Heightened Sensitivity Scale; Penn Spasm Frequency Scale, PSFS), disability (Oswestry Disability Index, ODI; Pain Disability Index, PDI), depression (Patient Health Questionnaire-9, PHQ-9), sleep (Pittsburgh Sleep Quality Index, PSQI), fatigue (Fatigue Severity Scale, FSS), pain (Numerical Pain Rating Scale, NPRS), quality of life (EuroQoL 5 Dimension 5 Level, EQ-5D-5L), and medication usage were assessed at baseline, 6-month, and 10-month postimplantation.

Results: ODI, PHQ-9, FSS, NPRS, PSQI, and EQ-5D-5L scores showed a notable change from baseline and surpassed the defined minimal clinically important difference (MCID) at 6-month and 10-month follow-up. Oral medication dosages were reduced.

Conclusions: The novel use of SCS therapy in seropositive SPS resulted in functional improvement and attenuation of symptoms. We present possible mechanisms by which SCS may produce clinical response in patients with SPS and aim to demonstrate proof-of-concept for a future comprehensive pilot study evaluating SCS-mediated response in SPS.

背景:僵人综合征(SPS)是一种罕见的神经免疫性疾病,其特征是由于自身免疫介导的神经元过度兴奋而导致的僵直和疼痛性痉挛,主要影响躯干和脊柱旁肌肉组织。脊髓刺激(SCS)是一种已获批准的治疗方法,可用于治疗疼痛性神经病,包括糖尿病周围神经病变和难治性心绞痛。我们描述了使用 SCS 治疗一名 49 岁血清反应阳性僵人综合征(SPS)患者痉挛和僵直的新方法。该患者接受了长达 13 个月的静脉注射免疫球蛋白 (IVIG) 和口服药物治疗,但病情改善甚微,这促使他考虑接受 SCS 治疗。据我们所知,这是第一份成功使用 SCS 治疗 SPS 并显示多方面临床改善的报告:临时 SCS 试验成功后,进行了永久性植入。痉挛/僵硬度(僵硬度分布指数;高度敏感性量表;宾州痉挛频率量表,PSFS)、残疾(Oswestry 残疾指数,ODI;患者健康问卷-9,PHQ-9)、睡眠(匹兹堡睡眠质量指数,PSQI)、疲劳(疲劳严重程度量表,FSS)、疼痛(数字疼痛评分量表,NPRS)、生活质量(EuroQoL 5 Dimension 5 Level,EQ-5D-5L)以及药物使用情况分别在基线、植入后 6 个月和 10 个月进行了评估。结果如下ODI、PHQ-9、FSS、NPRS、PSQI和EQ-5D-5L评分与基线相比有显著变化,并在6个月和10个月的随访中超过了定义的最小临床重要差异(MCID)。口服药物的剂量也有所减少:结论:SCS疗法在血清反应阳性SPS患者中的新应用改善了患者的功能并减轻了症状。我们提出了SCS对SPS患者产生临床反应的可能机制,旨在为未来评估SCS介导的SPS反应的综合试验研究提供概念证明。
{"title":"Spinal cord stimulation for the symptomatic treatment of rigidity and painful spasm in a case of stiff person syndrome.","authors":"Janus Patel, Emily Deschler, Enrique Galang","doi":"10.1111/papr.13340","DOIUrl":"10.1111/papr.13340","url":null,"abstract":"<p><strong>Background: </strong>Stiff person syndrome (SPS) is a rare neuroimmunological disorder characterized by rigidity and painful spasm primarily affecting the truncal and paraspinal musculature due to autoimmune-mediated neuronal hyperexcitability. Spinal cord stimulation (SCS) is an approved therapy for managing painful neuropathic conditions, including diabetic peripheral neuropathy and refractory angina pectoris. We describe the novel use of SCS for the treatment of spasm and rigidity in a 49-year-old man with seropositive stiff person syndrome (SPS). The patient was treated with intravenous immunoglobulin (IVIG) and oral medications over a 13-month period with minimal improvement, prompting consideration of SCS. To our knowledge, this is the first report of the successful use of SCS in SPS with the demonstration of multifaceted clinical improvement.</p><p><strong>Methods: </strong>Following a successful temporary SCS trial, permanent implantation was performed. Spasm/stiffness (Distribution of Stiffness Index; Heightened Sensitivity Scale; Penn Spasm Frequency Scale, PSFS), disability (Oswestry Disability Index, ODI; Pain Disability Index, PDI), depression (Patient Health Questionnaire-9, PHQ-9), sleep (Pittsburgh Sleep Quality Index, PSQI), fatigue (Fatigue Severity Scale, FSS), pain (Numerical Pain Rating Scale, NPRS), quality of life (EuroQoL 5 Dimension 5 Level, EQ-5D-5L), and medication usage were assessed at baseline, 6-month, and 10-month postimplantation.</p><p><strong>Results: </strong>ODI, PHQ-9, FSS, NPRS, PSQI, and EQ-5D-5L scores showed a notable change from baseline and surpassed the defined minimal clinically important difference (MCID) at 6-month and 10-month follow-up. Oral medication dosages were reduced.</p><p><strong>Conclusions: </strong>The novel use of SCS therapy in seropositive SPS resulted in functional improvement and attenuation of symptoms. We present possible mechanisms by which SCS may produce clinical response in patients with SPS and aim to demonstrate proof-of-concept for a future comprehensive pilot study evaluating SCS-mediated response in SPS.</p>","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":" ","pages":"798-804"},"PeriodicalIF":2.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pain characterization in patients with Parkinson's disease. 帕金森病患者的疼痛特征。
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-01 Epub Date: 2024-01-31 DOI: 10.1111/papr.13352
Ana Carolinne Rodrigues Nogueira, Karyne Corrêa Pereira, Vinício Ferreira Rodrigues, Danielle De Paula Aprígio Alves, Juliana Bittencourt Marques, Estêvão Rios Monteiro, Igor Ramathur Telles De Jesus

Background: Patients with Parkinson's disease (PD) often report chronic pain, which is one of the most complex non-motor symptoms. Therefore, this study aims to review the literature on the characteristics of pain in patients with PD.

Methods: A systematic literature review was conducted following MOOSE recommendations. Observational studies reporting pain in patients with PD were included. No time restrictions were applied, but studies in Portuguese, Spanish, and English were considered. The search was performed in PubMed®, LILACS, and SciELO databases.

Results: Twenty-six articles of observational studies were identified, reporting an average pain prevalence of 67.36%, emphasizing the significance of this symptom in the PD population. Pain was reported in various body regions, including lower limbs, upper limbs, lumbar spine, cervical spine, and other joints. Pain classification varied, encompassing musculoskeletal pain, PD-related pain, neuropathic pain, and dystonic pain, among others.

Discussion: Pain in patients with PD is a prevalent and multifactorial condition, significantly impacting patients' quality of life.

Conclusion: Heterogeneity in data across included studies was observed, highlighting the need for additional research to elucidate the underlying mechanisms of pain in patients with PD and develop effective therapeutic strategies to address this symptom and improve the quality of life for individuals living with the disease.

背景:帕金森病(PD)患者经常报告慢性疼痛,这是最复杂的非运动症状之一。因此,本研究旨在回顾有关帕金森病患者疼痛特征的文献:方法:根据 MOOSE 建议进行了系统性文献综述。方法:根据 MOOSE 建议进行了系统性文献综述,纳入了报告帕金森病患者疼痛的观察性研究。没有时间限制,但考虑了葡萄牙语、西班牙语和英语的研究。检索在 PubMed®、LILACS 和 SciELO 数据库中进行:结果:共发现 26 篇观察性研究文章,报告的平均疼痛发生率为 67.36%,强调了这一症状在帕金森病患者中的重要性。据报道,疼痛发生在不同的身体部位,包括下肢、上肢、腰椎、颈椎和其他关节。疼痛的分类多种多样,包括肌肉骨骼疼痛、与帕金森病相关的疼痛、神经病理性疼痛和肌张力障碍性疼痛等:讨论:帕金森病患者的疼痛是一种普遍存在的多因素疾病,严重影响患者的生活质量:结论:纳入研究的数据存在异质性,因此需要开展更多研究,以阐明帕金森病患者疼痛的潜在机制,并开发有效的治疗策略来解决这一症状,改善患者的生活质量。
{"title":"Pain characterization in patients with Parkinson's disease.","authors":"Ana Carolinne Rodrigues Nogueira, Karyne Corrêa Pereira, Vinício Ferreira Rodrigues, Danielle De Paula Aprígio Alves, Juliana Bittencourt Marques, Estêvão Rios Monteiro, Igor Ramathur Telles De Jesus","doi":"10.1111/papr.13352","DOIUrl":"10.1111/papr.13352","url":null,"abstract":"<p><strong>Background: </strong>Patients with Parkinson's disease (PD) often report chronic pain, which is one of the most complex non-motor symptoms. Therefore, this study aims to review the literature on the characteristics of pain in patients with PD.</p><p><strong>Methods: </strong>A systematic literature review was conducted following MOOSE recommendations. Observational studies reporting pain in patients with PD were included. No time restrictions were applied, but studies in Portuguese, Spanish, and English were considered. The search was performed in PubMed®, LILACS, and SciELO databases.</p><p><strong>Results: </strong>Twenty-six articles of observational studies were identified, reporting an average pain prevalence of 67.36%, emphasizing the significance of this symptom in the PD population. Pain was reported in various body regions, including lower limbs, upper limbs, lumbar spine, cervical spine, and other joints. Pain classification varied, encompassing musculoskeletal pain, PD-related pain, neuropathic pain, and dystonic pain, among others.</p><p><strong>Discussion: </strong>Pain in patients with PD is a prevalent and multifactorial condition, significantly impacting patients' quality of life.</p><p><strong>Conclusion: </strong>Heterogeneity in data across included studies was observed, highlighting the need for additional research to elucidate the underlying mechanisms of pain in patients with PD and develop effective therapeutic strategies to address this symptom and improve the quality of life for individuals living with the disease.</p>","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":" ","pages":"786-797"},"PeriodicalIF":2.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139642688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What’s important in a contract beyond the salary? A primer for pain physicians and trainees 除工资外,合同中还有哪些重要内容?疼痛科医生和实习生入门指南
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-04-16 DOI: 10.1111/papr.13377
Tetyana Marshall, Maria Eibel, Brett Marshall, Andrew Clary, Sergio Hickey, Patrick Polsunas, Alex Dresslor, Neal Shah, Cathy Zhang, Danielle Zheng, Trent Emerick
This manuscript is designed to complement the previously published primer on salary structures for new pain physicians. The previous manuscript “Employment Contract Financial Models for the Pain Physician: A Primer” had a goal of increasing understanding of financial models by pain fellows when preparing for contract negotiations. This manuscript illustrates the many equally important considerations of “non-monetary” values that are a significant part of contract negotiation outside of salary. It contributes to the overall education for trainees and pain physicians on benefits and job responsibilities.
本手稿旨在补充之前出版的有关新疼痛科医生薪酬结构的入门读物。之前的手稿 "疼痛科医生的雇佣合同财务模型:的目的是让疼痛科医师在准备合同谈判时加深对财务模型的理解。本手稿说明了许多同样重要的 "非货币 "价值考虑因素,这些因素是合同谈判中工资以外的重要部分。它有助于对受训者和疼痛科医生进行有关福利和工作职责的整体教育。
{"title":"What’s important in a contract beyond the salary? A primer for pain physicians and trainees","authors":"Tetyana Marshall, Maria Eibel, Brett Marshall, Andrew Clary, Sergio Hickey, Patrick Polsunas, Alex Dresslor, Neal Shah, Cathy Zhang, Danielle Zheng, Trent Emerick","doi":"10.1111/papr.13377","DOIUrl":"https://doi.org/10.1111/papr.13377","url":null,"abstract":"This manuscript is designed to complement the previously published primer on salary structures for new pain physicians. The previous manuscript “Employment Contract Financial Models for the Pain Physician: A Primer” had a goal of increasing understanding of financial models by pain fellows when preparing for contract negotiations. This manuscript illustrates the many equally important considerations of “non-monetary” values that are a significant part of contract negotiation outside of salary. It contributes to the overall education for trainees and pain physicians on benefits and job responsibilities.","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":"186 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140562959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6. Persistent spinal pain syndrome type 2 6.2 型持续性脊柱疼痛综合征
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-04-14 DOI: 10.1111/papr.13379
Johan van de Minkelis, Laurens Peene, Steven P. Cohen, Peter Staats, Adnan Al-Kaisy, Koen Van Boxem, Jan Willem Kallewaard, Jan Van Zundert
Persistent Spinal Pain Syndrome (PSPS) refers to chronic axial pain and/or extremity pain. Two subtypes have been defined: PSPS-type 1 is chronic pain without previous spinal surgery and PSPS-type 2 is chronic pain, persisting after spine surgery, and is formerly known as Failed Back Surgery Syndrome (FBSS) or post-laminectomy syndrome. The etiology of PSPS-type 2 can be gleaned using elements from the patient history, physical examination, and additional medical imaging. Origins of persistent pain following spinal surgery may be categorized into an inappropriate procedure (eg a lumbar fusion at an incorrect level or for sacroiliac joint [SIJ] pain); technical failure (eg operation at non-affected levels, retained disk fragment, pseudoarthrosis), biomechanical sequelae of surgery (eg adjacent segment disease or SIJ pain after a fusion to the sacrum, muscle wasting, spinal instability); and complications (eg battered root syndrome, excessive epidural fibrosis, and arachnoiditis), or undetermined.
持续性脊柱疼痛综合征(PSPS)是指慢性轴性疼痛和/或肢体疼痛。目前已定义了两种亚型:PSPS 1 型是指未接受过脊柱手术的慢性疼痛,PSPS 2 型是指脊柱手术后持续存在的慢性疼痛,以前被称为背部手术失败综合征(FBSS)或椎板切除术后综合征。PSPS 2 型的病因可通过患者的病史、体格检查和其他医学影像资料来了解。脊柱手术后持续疼痛的病因可分为不恰当的手术(如在不正确的水平进行腰椎融合术或骶髂关节疼痛);技术失败(如在非受影响水平进行手术、椎间盘碎片残留、假关节)、手术生物力学后遗症(如邻近节段疾病或骶骨融合术后的骶髂关节疼痛、肌肉萎缩、脊柱不稳定);以及并发症(如撞击根综合征、硬膜外过度纤维化和蛛网膜炎),或无法确定。
{"title":"6. Persistent spinal pain syndrome type 2","authors":"Johan van de Minkelis, Laurens Peene, Steven P. Cohen, Peter Staats, Adnan Al-Kaisy, Koen Van Boxem, Jan Willem Kallewaard, Jan Van Zundert","doi":"10.1111/papr.13379","DOIUrl":"https://doi.org/10.1111/papr.13379","url":null,"abstract":"Persistent Spinal Pain Syndrome (PSPS) refers to chronic axial pain and/or extremity pain. Two subtypes have been defined: PSPS-type 1 is chronic pain without previous spinal surgery and PSPS-type 2 is chronic pain, persisting after spine surgery, and is formerly known as Failed Back Surgery Syndrome (FBSS) or post-laminectomy syndrome. The etiology of PSPS-type 2 can be gleaned using elements from the patient history, physical examination, and additional medical imaging. Origins of persistent pain following spinal surgery may be categorized into an inappropriate procedure (eg a lumbar fusion at an incorrect level or for sacroiliac joint [SIJ] pain); technical failure (eg operation at non-affected levels, retained disk fragment, pseudoarthrosis), biomechanical sequelae of surgery (eg adjacent segment disease or SIJ pain after a fusion to the sacrum, muscle wasting, spinal instability); and complications (eg battered root syndrome, excessive epidural fibrosis, and arachnoiditis), or undetermined.","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":"23 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140562846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between number of prior lumbar spine surgeries and outcomes following spinal cord stimulator implantation: A multisite, retrospective pooled analysis 腰椎手术次数与脊髓刺激器植入术后疗效之间的关系:多地点回顾性汇总分析
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-04-12 DOI: 10.1111/papr.13371
Jonathan M. Hagedorn, Ryan S. D'Souza, Abhishek Yadav, Tony K. George, Nathan DeTemple, Erik Ovrom, Christopher M. Lam, Dawood Sayed, Morgan Hall, Lauren Stephenson, Zach Rivera, Bryan Hoelzer, Timothy R. Deer
Lumbar spine surgery is a common procedure for treating disabling spine-related pain. In recent decades, both the number and cost of spine surgeries have increased despite technological advances and modification in surgical technique. For those patients that have continued uncontrolled back and/or lower extremity pain following lumbar spine surgery, spinal cord stimulation (SCS) has emerged as a viable treatment option. However, the impact of lumbar spine surgical history remains largely unstudied. Specifically, the current study considers the impact of number of prior lumbar spine surgeries on pain relief outcomes following SCS implantation.
腰椎手术是治疗脊柱相关致残性疼痛的常见手术。近几十年来,尽管技术在不断进步,手术技巧也在不断改进,但脊柱手术的数量和费用却在不断增加。对于腰椎手术后仍无法控制背部和/或下肢疼痛的患者,脊髓刺激(SCS)已成为一种可行的治疗方案。然而,腰椎手术史的影响在很大程度上仍未得到研究。具体而言,本研究考虑了腰椎手术次数对 SCS 植入术后疼痛缓解效果的影响。
{"title":"Relationship between number of prior lumbar spine surgeries and outcomes following spinal cord stimulator implantation: A multisite, retrospective pooled analysis","authors":"Jonathan M. Hagedorn, Ryan S. D'Souza, Abhishek Yadav, Tony K. George, Nathan DeTemple, Erik Ovrom, Christopher M. Lam, Dawood Sayed, Morgan Hall, Lauren Stephenson, Zach Rivera, Bryan Hoelzer, Timothy R. Deer","doi":"10.1111/papr.13371","DOIUrl":"https://doi.org/10.1111/papr.13371","url":null,"abstract":"Lumbar spine surgery is a common procedure for treating disabling spine-related pain. In recent decades, both the number and cost of spine surgeries have increased despite technological advances and modification in surgical technique. For those patients that have continued uncontrolled back and/or lower extremity pain following lumbar spine surgery, spinal cord stimulation (SCS) has emerged as a viable treatment option. However, the impact of lumbar spine surgical history remains largely unstudied. Specifically, the current study considers the impact of number of prior lumbar spine surgeries on pain relief outcomes following SCS implantation.","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":"32 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140562954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiofrequency for chronic lumbosacral and cervical pain: Results of a consensus study using the RAND/UCLA appropriateness method 射频治疗慢性腰骶部和颈椎疼痛:采用兰德/加州大学洛杉矶分校适当性方法的共识研究结果
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-04-10 DOI: 10.1111/papr.13378
Javier de Andrés Ares, Sam Eldabe, Nicky Helsen, Ganesan Baranidharan, Jean‐Luc Barat, Arun Bhaskar, Fabrizio Cassini, Sebastian Gillner, Jan Willem Kallewaard, Stephan Klessinger, Philippe Mavrocordatos, Felice Occhigrossi, Jan Van Zundert, Frank Huygen, Herman Stoevelaar
BackgroundDespite the routine use of radiofrequency (RF) for the treatment of chronic pain in the lumbosacral and cervical region, there remains uncertainty on the most appropriate patient selection criteria. This study aimed to develop appropriateness criteria for RF in relation to relevant patient characteristics, considering RF ablation (RFA) for the treatment of chronic axial pain and pulsed RF (PRF) for the treatment of chronic radicular pain.MethodsThe RAND/UCLA Appropriateness Method (RUAM) was used to explore the opinions of a multidisciplinary European panel on the appropriateness of RFA and PRF for a variety of clinical scenarios. Depending on the type of pain (axial or radicular), the expert panel rated the appropriateness of RFA and PRF for a total of 219 clinical scenarios.ResultsFor axial pain in the lumbosacral or cervical region, appropriateness of RFA was determined by the dominant pain trigger and location of tenderness on palpation with higher appropriateness scores if these variables were suggestive of the diagnosis of facet or sacroiliac joint pain. Although the opinions on the appropriateness of PRF for lumbosacral and cervical radicular pain were fairly dispersed, there was agreement that PRF is an appropriate option for well‐selected patients with radicular pain due to herniated disc or foraminal stenosis, particularly in the absence of motor deficits. The panel outcomes were embedded in an educational e‐health tool that also covers the psychosocial aspects of chronic pain, providing integrated recommendations on the appropriate use of (P)RF interventions for the treatment of chronic axial and radicular pain in the lumbosacral and cervical region.ConclusionsA multidisciplinary European expert panel established patient‐specific recommendations that may support the (pre)selection of patients with chronic axial and radicular pain in the lumbosacral and cervical region for either RFA or PRF (accessible via https://rftool.org). Future studies should validate these recommendations by determining their predictive value for the outcomes of (P)RF interventions.
背景尽管射频(RF)已被常规用于治疗腰骶部和颈椎区域的慢性疼痛,但最合适的患者选择标准仍存在不确定性。本研究旨在根据相关患者的特征制定射频的适宜性标准,考虑射频消融(RFA)用于治疗慢性轴性疼痛和脉冲射频(PRF)用于治疗慢性根性疼痛。方法采用兰德/加州大学洛杉矶分校适宜性方法(RUAM)来探讨欧洲多学科专家小组对射频消融(RFA)和脉冲射频(PRF)在各种临床情况下的适宜性的意见。结果对于腰骶部或颈部的轴性疼痛,RFA的适宜性取决于主要的疼痛诱因和触诊触痛的位置,如果这些变量提示面关节或骶髂关节疼痛的诊断,则适宜性得分较高。尽管对腰骶部和颈椎根性疼痛是否适合进行 PRF 的意见相当不一致,但大家一致认为,PRF 是经过精心挑选的腰椎间盘突出或椎间孔狭窄引起的根性疼痛患者的适当选择,尤其是在没有运动障碍的情况下。专家小组的研究成果被嵌入到一个电子健康教育工具中,该工具还涵盖了慢性疼痛的社会心理方面,为适当使用(P)射频干预治疗腰骶部和颈部慢性轴性和根性疼痛提供了综合建议。结论欧洲多学科专家小组制定了针对特定患者的建议,这些建议可支持对腰骶部和颈部慢性轴性和根性疼痛患者进行(预)选择,使其接受RFA或PRF治疗(可通过https://rftool.org)。未来的研究应验证这些建议,确定其对(P)射频干预结果的预测价值。
{"title":"Radiofrequency for chronic lumbosacral and cervical pain: Results of a consensus study using the RAND/UCLA appropriateness method","authors":"Javier de Andrés Ares, Sam Eldabe, Nicky Helsen, Ganesan Baranidharan, Jean‐Luc Barat, Arun Bhaskar, Fabrizio Cassini, Sebastian Gillner, Jan Willem Kallewaard, Stephan Klessinger, Philippe Mavrocordatos, Felice Occhigrossi, Jan Van Zundert, Frank Huygen, Herman Stoevelaar","doi":"10.1111/papr.13378","DOIUrl":"https://doi.org/10.1111/papr.13378","url":null,"abstract":"BackgroundDespite the routine use of radiofrequency (RF) for the treatment of chronic pain in the lumbosacral and cervical region, there remains uncertainty on the most appropriate patient selection criteria. This study aimed to develop appropriateness criteria for RF in relation to relevant patient characteristics, considering RF ablation (RFA) for the treatment of chronic axial pain and pulsed RF (PRF) for the treatment of chronic radicular pain.MethodsThe RAND/UCLA Appropriateness Method (RUAM) was used to explore the opinions of a multidisciplinary European panel on the appropriateness of RFA and PRF for a variety of clinical scenarios. Depending on the type of pain (axial or radicular), the expert panel rated the appropriateness of RFA and PRF for a total of 219 clinical scenarios.ResultsFor axial pain in the lumbosacral or cervical region, appropriateness of RFA was determined by the dominant pain trigger and location of tenderness on palpation with higher appropriateness scores if these variables were suggestive of the diagnosis of facet or sacroiliac joint pain. Although the opinions on the appropriateness of PRF for lumbosacral and cervical radicular pain were fairly dispersed, there was agreement that PRF is an appropriate option for well‐selected patients with radicular pain due to herniated disc or foraminal stenosis, particularly in the absence of motor deficits. The panel outcomes were embedded in an educational e‐health tool that also covers the psychosocial aspects of chronic pain, providing integrated recommendations on the appropriate use of (P)RF interventions for the treatment of chronic axial and radicular pain in the lumbosacral and cervical region.ConclusionsA multidisciplinary European expert panel established patient‐specific recommendations that may support the (pre)selection of patients with chronic axial and radicular pain in the lumbosacral and cervical region for either RFA or PRF (accessible via <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"https://rftool.org\">https://rftool.org</jats:ext-link>). Future studies should validate these recommendations by determining their predictive value for the outcomes of (P)RF interventions.","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":"48 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140562844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of the term “migraineur” in the modern scientific literature 现代科学文献中 "偏头痛患者 "一词的使用
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-04-06 DOI: 10.1111/papr.13375
Sylvain Redon, Anne Donnet
{"title":"The use of the term “migraineur” in the modern scientific literature","authors":"Sylvain Redon, Anne Donnet","doi":"10.1111/papr.13375","DOIUrl":"https://doi.org/10.1111/papr.13375","url":null,"abstract":"","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":"47 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140562855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treating neuropathic pain and comorbid affective disorders: Preclinical and clinical evidence 治疗神经性疼痛和合并情感障碍:临床前和临床证据
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-04-04 DOI: 10.1111/papr.13370
David Richer Araujo Coelho, Maia Gersten, Alma Sanchez Jimenez, Felipe Fregni, Paolo Cassano, Willians Fernando Vieira
IntroductionNeuropathic pain (NP) significantly impacts quality of life and often coexists with affective disorders such as anxiety and depression. Addressing both NP and its psychiatric manifestations requires a comprehensive understanding of therapeutic options. This study aimed to review the main pharmacological and non‐pharmacological treatments for NP and comorbid affective disorders to describe their mechanisms of action and how they are commonly used in clinical practice.MethodsA review was conducted across five electronic databases, focusing on pharmacological and non‐pharmacological treatments for NP and its associated affective disorders. The following combination of MeSH and title/abstract keywords were used: “neuropathic pain,” “affective disorders,” “depression,” “anxiety,” “treatment,” and “therapy.” Both animal and human studies were included to discuss the underlying therapeutic mechanisms of these interventions.ResultsPharmacological interventions, including antidepressants, anticonvulsants, and opioids, modulate neural synaptic transmission to alleviate NP. Topical agents, such as capsaicin, lidocaine patches, and botulinum toxin A, offer localized relief by desensitizing pain pathways. Some of these drugs, especially antidepressants, also treat comorbid affective disorders. Non‐pharmacological techniques, including repetitive transcranial magnetic stimulation, transcranial direct current stimulation, and photobiomodulation therapy, modulate cortical activity and have shown promise for NP and mood disorders.ConclusionsThe interconnection between NP and comorbid affective disorders necessitates holistic therapeutic strategies. Some pharmacological treatments can be used for both conditions, and non‐pharmacological interventions have emerged as promising complementary approaches. Future research should explore novel molecular pathways to enhance treatment options for these interrelated conditions.
导言神经病理性疼痛(NP)严重影响生活质量,并经常与焦虑和抑郁等情感障碍同时存在。要同时治疗神经病理性疼痛及其精神表现,就必须全面了解各种治疗方案。本研究旨在综述治疗 NP 和合并情感障碍的主要药物和非药物治疗方法,以描述其作用机制以及在临床实践中的常用方法。使用了以下 MeSH 和标题/摘要关键词组合:"神经性疼痛"、"情感障碍"、"抑郁"、"焦虑"、"治疗 "和 "疗法"。结果药物干预,包括抗抑郁药、抗惊厥药和阿片类药物,可调节神经突触传递以缓解神经性疼痛。外用药物,如辣椒素、利多卡因贴片和 A 型肉毒杆菌毒素,可通过对疼痛通路脱敏来提供局部缓解。其中一些药物,尤其是抗抑郁药,还能治疗合并的情感障碍。非药物技术,包括重复经颅磁刺激、经颅直流电刺激和光生物调节疗法,可调节大脑皮层的活动,并显示出治疗 NP 和情绪障碍的前景。一些药物治疗方法可同时用于这两种疾病,而非药物干预方法则是一种很有前景的补充方法。未来的研究应探索新的分子途径,以加强这些相互关联疾病的治疗方案。
{"title":"Treating neuropathic pain and comorbid affective disorders: Preclinical and clinical evidence","authors":"David Richer Araujo Coelho, Maia Gersten, Alma Sanchez Jimenez, Felipe Fregni, Paolo Cassano, Willians Fernando Vieira","doi":"10.1111/papr.13370","DOIUrl":"https://doi.org/10.1111/papr.13370","url":null,"abstract":"IntroductionNeuropathic pain (NP) significantly impacts quality of life and often coexists with affective disorders such as anxiety and depression. Addressing both NP and its psychiatric manifestations requires a comprehensive understanding of therapeutic options. This study aimed to review the main pharmacological and non‐pharmacological treatments for NP and comorbid affective disorders to describe their mechanisms of action and how they are commonly used in clinical practice.MethodsA review was conducted across five electronic databases, focusing on pharmacological and non‐pharmacological treatments for NP and its associated affective disorders. The following combination of MeSH and title/abstract keywords were used: “neuropathic pain,” “affective disorders,” “depression,” “anxiety,” “treatment,” and “therapy.” Both animal and human studies were included to discuss the underlying therapeutic mechanisms of these interventions.ResultsPharmacological interventions, including antidepressants, anticonvulsants, and opioids, modulate neural synaptic transmission to alleviate NP. Topical agents, such as capsaicin, lidocaine patches, and botulinum toxin A, offer localized relief by desensitizing pain pathways. Some of these drugs, especially antidepressants, also treat comorbid affective disorders. Non‐pharmacological techniques, including repetitive transcranial magnetic stimulation, transcranial direct current stimulation, and photobiomodulation therapy, modulate cortical activity and have shown promise for NP and mood disorders.ConclusionsThe interconnection between NP and comorbid affective disorders necessitates holistic therapeutic strategies. Some pharmacological treatments can be used for both conditions, and non‐pharmacological interventions have emerged as promising complementary approaches. Future research should explore novel molecular pathways to enhance treatment options for these interrelated conditions.","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":"28 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140562856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors Index 作者索引
IF 2.6 3区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-04-02 DOI: 10.1111/papr.13360
<p><b>A</b></p><p>Abd Elsayed A.OP-06</p><p>Ahmadi R.PP-58</p><p>Ahmed R.S.PP-38</p><p>Akar O. OP-08</p><p>Akbaş M. OP-27, SP-31, SP-32</p><p>Akin Takmaz S. PP-62</p><p>Akkaya Ömer T. OP-01</p><p>Aksoy M.E. SP-18</p><p>Alimian M. PP-31</p><p>Allet M. PP-25</p><p>Allet S. PP-25</p><p>Anitescu M. OP-11</p><p>Anwar S. PP-05</p><p>Arkan Tuna H.OP-04, OP-25, PP-13, PP-29</p><p>Asik I.OP-08</p><p>Aşik I.OP-22</p><p>Aşkin Turan S.OP-15, OP-20, PP-16</p><p>Aslam M.PP-05</p><p>Asmara Y.R.Y.PP-03</p><p>Atallah J.OP-26, PP-44</p><p>Aukes H.PP-59</p><p>Aydin Ş.OP-15, OP-20</p><p><b>B</b></p><p>Bakir M.PP-63</p><p>Bakshi S.G.OP-10, PP-30, PP-61</p><p>Balaban D.OP-22</p><p>Baranidharan G.OP-24</p><p>Barat J.L.OP-24</p><p>Barrett S.PP-04</p><p>Batra A.PP-14, PP-34</p><p>Batra J.PP-14, PP-34</p><p>Battilana M.PP-35</p><p>Bayerl S.PP-56</p><p>Belaid H.PP-54</p><p>Bendel M.OP-07</p><p>Benedetti F.SP-01, SP-02</p><p>Berg A.PP-50</p><p>Bergmans T.PP-39</p><p>Bhaskar A.OP-24</p><p>Bhoi D.OP-23</p><p>Biesemans T.PP-48</p><p>Bode B.PP-04</p><p>Bojrab L.PP-20</p><p>Bonavina G.PP-35</p><p>Bougeard R.PP-54</p><p>Brewer R.PP-20</p><p>Bruehl S.SP-03, SP-04</p><p>Buschman R.PP-04</p><p>Buyse K.PP-39</p><p><b>C</b></p><p>Cadide D.M.OP-14</p><p>Calodney A.OP-07, PP-53</p><p>Camolesi E.PP-25</p><p>Canos Verdecho M.A.PP-54, PP-56</p><p>Capello M.G.MOP-14</p><p>Caraway D.OP-07</p><p>Cassini F.OP-24, PP-42, PP-43</p><p>Castellani G.B.PP-35</p><p>Çelik Ilhan S.OP-04</p><p>Cervera S.B.OP-13</p><p>Chair M.PP-08</p><p>Chatterjee A.PP-30</p><p>Chaudhari N.PP-40</p><p>Chauhan H.PP-14, PP-34</p><p>Chen L.OP-21, PP-42, PP-43, PP-53, PP-54, PP-55, PP-56</p><p>Chua N.H.PP-37</p><p>Cohen S.P.SP-15, SP-16, SP-17</p><p>Cömert A.OP-01</p><p>Comlek S.PP-19</p><p><b>D</b></p><p>Dağistan G.OP-12, OP-27, SP-30, SP-33</p><p>Dankerlui R.PP-32</p><p>Danko M.OP-26, PP-44</p><p>Dann T.PP-04</p><p>Darmawan G.PP-08</p><p>Darnall B.OP-18</p><p>De Andrés J.PP-49</p><p>De Andres ARES J.SP-19, SP-20, SP-22</p><p>De Andrés ARES J.OP-24</p><p>De Minkelis J.PP-59</p><p>De Negri P.PP-54</p><p>De Ridder D.SP-17, SP-26</p><p>Deligoz O.OP-04</p><p>Deri D.PP-29</p><p>Devor M.SP-36, SP-37, SP-38, SP-39, SP-40</p><p>Di Mauro L.PP-36</p><p>Dorenkamp C.PP-57</p><p>Durmuşoğlu Ü.OP-16</p><p><b>E</b></p><p>Eerlings S.PP-45</p><p>Eggington S.PP-60</p><p>Eglseer D.OP-17</p><p>El Tallawy S.N.PP-38</p><p>Eldabe S.OP-24</p><p>Elkholy A.PP-11</p><p>Elkholy W.PP-11</p><p>Elzinga L.PP-59</p><p>Emami A.PP-31</p><p>Erdine S.SP-34, SP-35</p><p>Ergisi M.PP-40</p><p>Ertargin M.PP-17, PP-47, PP-63</p><p>Esen K.PP-47</p><p>Eyigor C.OP-09</p><p><b>F</b></p><p>Fallatah S.M.A.OP-05</p><p>Fernández A.PP-49</p><p>Ferro R.PP-51, PP-52, PP-57</p><p>Figueiras G.PP-02</p><p>Fishman M.OP-06, PP-04</p><p>Fonseca C.B.PP-12</p><p>Franco M.S.OP-13</p><p><b>G</b></p><p>Gage E.PP-52</p><p>Gemae M.R.PP-09</p><p>Generoso L.POP-14
OP-06Ahmadi R.PP-58Ahmed R.S.PP-38Akar O.OP-08Akbaş M. OP-27, SP-31, SP-32Akin Takmaz S. PP-62Akkaya Ömer T. OP-01Aksoy M.E. SP-18Alimian M. OP-27, SP-31, SP-32OP-01Aksoy M.E. SP-18Alimian M. PP-31Allet M. PP-25Allet S. PP-25Anitescu M. OP-11Anwar S. PP-05Arkan Tuna H. OP-04、OP-25、PP-13、PP-29Asik I. OP-08Aşik I. OP-22Aşkin Turan S. OP-15、OP-20、PP-16A.OP-15, OP-20, PP-16Aslam M.PP-05Asmara Y.R.Y.PP-03Atallah J.OP-26, PP-44Aukes H.PP-59Aydin Ş.OP-15, OP-20BBakir M.PP-63Bakshi S.G.OP-10, PP-30, PP-61Balaban D.OP-22Baranidharan G.OP-24Barat J.L.OP-24Barrett S.PP-04Batra A.PP-14, PP-34Batra J.PP-14, PP-34Battilana M.PP-35Bayerl S.PP-56Belaid H.PP-54Bendel M.OP-07Benedetti F. OP-07.SP-01, SP-02Berg A.PP-50Bergmans T.PP-39Bhaskar A.OP-24Bhoi D.OP-23Biesemans T.PP-48Bode B.PP-04Bojrab L.PP-20Bonavina G.PP-35Bougeard R.PP-54Brewer R. P.PP-20Bruehl S. P.P.PP-20Bruehl S.SP-03 SP-04Buschman R.PP-04Buyse K.PP-39CCadide D.M.OP-14Calodney A.OP-07, PP-53Camolesi E.PP-25Canos Verdecho M.A.PP-54, PP-56Capello M.G.MOP-14Caraway D. OP-07Cassini F.OP-04Buschman R.PP-04Buyse K.PP-39OP-07Cassini F.OP-24, PP-42, PP-43Castellani G.B.PP-35Çelik Ilhan S.OP-04Cervera S.B.OP-13Chair M.PP-08Chatterjee A.PP-30Chaudhari N.PP-40Chauhan H.PP-14, PP-34Chen L. OP-21, PP-42, PP-43OP-21, PP-42, PP-43, PP-53, PP-54, PP-55, PP-56Chua N.H.PP-37Cohen S.P.SP-15, SP-16, SP-17Cömert A.OP-01Comlek S.PP-19DDağistan G.OP-12, OP-27, SP-30, SP-33Dankerlui R.PP-59De Negri P.PP-54De Ridder D.SP-17、SP-26Deligoz O.OP-04Deri D.PP-29Devor M.SP-36、SP-37、SP-38、SP-39、SP-40Di Mauro L.PP-36Dorenkamp C.PP-57Durmuşoğlu Ü.OP-16Eerlings S.PP-45Eggington S.PP-60Eglseer D.OP-17El Tallawy S.N.PP-38Eldabe S.OP-24Elkholy A.PP-11Elkholy W.PP-11Elzinga L.PP-59Emami A.PP-31Erdine S.SP-34, SP-35Ergisi M.PP-40Ertargin M.PP-17、PP-47、PP-63Esen K.PP-47Eyigor C.OP-09Fallatah S.M.A.OP-05Fernández A.PP-49Ferro R.PP-51、PP-52、PP-57Figueiras G.PP-02Fishman M.OP-06, PP-04Fonseca C.B.PP-12Franco M.S.OP-13Gage E.PP-52Gemae M.R.PP-09Generoso L.POP-14Gezer A.OP-09Gillner S.OP-24Gjika A.OP-03Gleave A.PP-41Glover A.PP-04Goldberg E. OP-11, OP-21, PP-47OP-11, OP-21, PP-42, PP-43, PP-50, PP-51, PP-52, PP-55, PP-56, PP-57Gomez F.C.OP-13Gonullu E.OP-08Gudin J.PP-10, PP-15Gültuna I.PP-59Gündüz O.H.PP-46Güngör Y.OP-01Gür V.E.OP-27Gursoy G.OP-25Haas S.OP-26, PP-44Hamijoyo L.PP-08Hammond B.PP-50Hans G.PP-32Hassan M.W.PP-05Hegarty D.A.PP-23, PP-64Hegarty D.A.OP-06Helsen N. OP-24, PP-58Höör Y. OP-24, PP-59OP-24, PP-58Hödl M.OP-17Holt B.OP-26, PP-44Hurwitz P.PP-10, PP-15Hussain S.Y.OP-23Huygen F.PP-58IIbrahim M.PP-20Ilhan S.OP-08Imani F.PP-31Iqbal M.OP-26, PP-44Irshad K. OP-26, PP-44PP-01Işik R.PP-46Jain D.OP-23Jameson J.OP-07Jawaid H.PP-01Jenner C.PP-40Jiménez F.PP-49Johanek L.PP-04Johnson C.OP-07Jorissen S.PP-07Joshi M.OP-10Kallewaard J.W.0191Kallewaard J.W.0190, OP-24, PP-54, PP-56Kapural L.OP-07Karabakan G.PP-16Karadağ Erkoç S.OP-22Karaduman Y.PP-62Kazemi Haki B.0184Khan A.PP-09, PP-41Khan G.R.PP-05Khosravi N.PP-31Klessinger S.OP-24Kloster D.O
{"title":"Authors Index","authors":"","doi":"10.1111/papr.13360","DOIUrl":"https://doi.org/10.1111/papr.13360","url":null,"abstract":"&lt;p&gt;\u0000&lt;b&gt;A&lt;/b&gt;\u0000&lt;/p&gt;\u0000&lt;p&gt;Abd Elsayed A.OP-06&lt;/p&gt;\u0000&lt;p&gt;Ahmadi R.PP-58&lt;/p&gt;\u0000&lt;p&gt;Ahmed R.S.PP-38&lt;/p&gt;\u0000&lt;p&gt;Akar O. OP-08&lt;/p&gt;\u0000&lt;p&gt;Akbaş M. OP-27, SP-31, SP-32&lt;/p&gt;\u0000&lt;p&gt;Akin Takmaz S. PP-62&lt;/p&gt;\u0000&lt;p&gt;Akkaya Ömer T. OP-01&lt;/p&gt;\u0000&lt;p&gt;Aksoy M.E. SP-18&lt;/p&gt;\u0000&lt;p&gt;Alimian M. PP-31&lt;/p&gt;\u0000&lt;p&gt;Allet M. PP-25&lt;/p&gt;\u0000&lt;p&gt;Allet S. PP-25&lt;/p&gt;\u0000&lt;p&gt;Anitescu M. OP-11&lt;/p&gt;\u0000&lt;p&gt;Anwar S. PP-05&lt;/p&gt;\u0000&lt;p&gt;Arkan Tuna H.OP-04, OP-25, PP-13, PP-29&lt;/p&gt;\u0000&lt;p&gt;Asik I.OP-08&lt;/p&gt;\u0000&lt;p&gt;Aşik I.OP-22&lt;/p&gt;\u0000&lt;p&gt;Aşkin Turan S.OP-15, OP-20, PP-16&lt;/p&gt;\u0000&lt;p&gt;Aslam M.PP-05&lt;/p&gt;\u0000&lt;p&gt;Asmara Y.R.Y.PP-03&lt;/p&gt;\u0000&lt;p&gt;Atallah J.OP-26, PP-44&lt;/p&gt;\u0000&lt;p&gt;Aukes H.PP-59&lt;/p&gt;\u0000&lt;p&gt;Aydin Ş.OP-15, OP-20&lt;/p&gt;\u0000&lt;p&gt;\u0000&lt;b&gt;B&lt;/b&gt;\u0000&lt;/p&gt;\u0000&lt;p&gt;Bakir M.PP-63&lt;/p&gt;\u0000&lt;p&gt;Bakshi S.G.OP-10, PP-30, PP-61&lt;/p&gt;\u0000&lt;p&gt;Balaban D.OP-22&lt;/p&gt;\u0000&lt;p&gt;Baranidharan G.OP-24&lt;/p&gt;\u0000&lt;p&gt;Barat J.L.OP-24&lt;/p&gt;\u0000&lt;p&gt;Barrett S.PP-04&lt;/p&gt;\u0000&lt;p&gt;Batra A.PP-14, PP-34&lt;/p&gt;\u0000&lt;p&gt;Batra J.PP-14, PP-34&lt;/p&gt;\u0000&lt;p&gt;Battilana M.PP-35&lt;/p&gt;\u0000&lt;p&gt;Bayerl S.PP-56&lt;/p&gt;\u0000&lt;p&gt;Belaid H.PP-54&lt;/p&gt;\u0000&lt;p&gt;Bendel M.OP-07&lt;/p&gt;\u0000&lt;p&gt;Benedetti F.SP-01, SP-02&lt;/p&gt;\u0000&lt;p&gt;Berg A.PP-50&lt;/p&gt;\u0000&lt;p&gt;Bergmans T.PP-39&lt;/p&gt;\u0000&lt;p&gt;Bhaskar A.OP-24&lt;/p&gt;\u0000&lt;p&gt;Bhoi D.OP-23&lt;/p&gt;\u0000&lt;p&gt;Biesemans T.PP-48&lt;/p&gt;\u0000&lt;p&gt;Bode B.PP-04&lt;/p&gt;\u0000&lt;p&gt;Bojrab L.PP-20&lt;/p&gt;\u0000&lt;p&gt;Bonavina G.PP-35&lt;/p&gt;\u0000&lt;p&gt;Bougeard R.PP-54&lt;/p&gt;\u0000&lt;p&gt;Brewer R.PP-20&lt;/p&gt;\u0000&lt;p&gt;Bruehl S.SP-03, SP-04&lt;/p&gt;\u0000&lt;p&gt;Buschman R.PP-04&lt;/p&gt;\u0000&lt;p&gt;Buyse K.PP-39&lt;/p&gt;\u0000&lt;p&gt;\u0000&lt;b&gt;C&lt;/b&gt;\u0000&lt;/p&gt;\u0000&lt;p&gt;Cadide D.M.OP-14&lt;/p&gt;\u0000&lt;p&gt;Calodney A.OP-07, PP-53&lt;/p&gt;\u0000&lt;p&gt;Camolesi E.PP-25&lt;/p&gt;\u0000&lt;p&gt;Canos Verdecho M.A.PP-54, PP-56&lt;/p&gt;\u0000&lt;p&gt;Capello M.G.MOP-14&lt;/p&gt;\u0000&lt;p&gt;Caraway D.OP-07&lt;/p&gt;\u0000&lt;p&gt;Cassini F.OP-24, PP-42, PP-43&lt;/p&gt;\u0000&lt;p&gt;Castellani G.B.PP-35&lt;/p&gt;\u0000&lt;p&gt;Çelik Ilhan S.OP-04&lt;/p&gt;\u0000&lt;p&gt;Cervera S.B.OP-13&lt;/p&gt;\u0000&lt;p&gt;Chair M.PP-08&lt;/p&gt;\u0000&lt;p&gt;Chatterjee A.PP-30&lt;/p&gt;\u0000&lt;p&gt;Chaudhari N.PP-40&lt;/p&gt;\u0000&lt;p&gt;Chauhan H.PP-14, PP-34&lt;/p&gt;\u0000&lt;p&gt;Chen L.OP-21, PP-42, PP-43, PP-53, PP-54, PP-55, PP-56&lt;/p&gt;\u0000&lt;p&gt;Chua N.H.PP-37&lt;/p&gt;\u0000&lt;p&gt;Cohen S.P.SP-15, SP-16, SP-17&lt;/p&gt;\u0000&lt;p&gt;Cömert A.OP-01&lt;/p&gt;\u0000&lt;p&gt;Comlek S.PP-19&lt;/p&gt;\u0000&lt;p&gt;\u0000&lt;b&gt;D&lt;/b&gt;\u0000&lt;/p&gt;\u0000&lt;p&gt;Dağistan G.OP-12, OP-27, SP-30, SP-33&lt;/p&gt;\u0000&lt;p&gt;Dankerlui R.PP-32&lt;/p&gt;\u0000&lt;p&gt;Danko M.OP-26, PP-44&lt;/p&gt;\u0000&lt;p&gt;Dann T.PP-04&lt;/p&gt;\u0000&lt;p&gt;Darmawan G.PP-08&lt;/p&gt;\u0000&lt;p&gt;Darnall B.OP-18&lt;/p&gt;\u0000&lt;p&gt;De Andrés J.PP-49&lt;/p&gt;\u0000&lt;p&gt;De Andres ARES J.SP-19, SP-20, SP-22&lt;/p&gt;\u0000&lt;p&gt;De Andrés ARES J.OP-24&lt;/p&gt;\u0000&lt;p&gt;De Minkelis J.PP-59&lt;/p&gt;\u0000&lt;p&gt;De Negri P.PP-54&lt;/p&gt;\u0000&lt;p&gt;De Ridder D.SP-17, SP-26&lt;/p&gt;\u0000&lt;p&gt;Deligoz O.OP-04&lt;/p&gt;\u0000&lt;p&gt;Deri D.PP-29&lt;/p&gt;\u0000&lt;p&gt;Devor M.SP-36, SP-37, SP-38, SP-39, SP-40&lt;/p&gt;\u0000&lt;p&gt;Di Mauro L.PP-36&lt;/p&gt;\u0000&lt;p&gt;Dorenkamp C.PP-57&lt;/p&gt;\u0000&lt;p&gt;Durmuşoğlu Ü.OP-16&lt;/p&gt;\u0000&lt;p&gt;\u0000&lt;b&gt;E&lt;/b&gt;\u0000&lt;/p&gt;\u0000&lt;p&gt;Eerlings S.PP-45&lt;/p&gt;\u0000&lt;p&gt;Eggington S.PP-60&lt;/p&gt;\u0000&lt;p&gt;Eglseer D.OP-17&lt;/p&gt;\u0000&lt;p&gt;El Tallawy S.N.PP-38&lt;/p&gt;\u0000&lt;p&gt;Eldabe S.OP-24&lt;/p&gt;\u0000&lt;p&gt;Elkholy A.PP-11&lt;/p&gt;\u0000&lt;p&gt;Elkholy W.PP-11&lt;/p&gt;\u0000&lt;p&gt;Elzinga L.PP-59&lt;/p&gt;\u0000&lt;p&gt;Emami A.PP-31&lt;/p&gt;\u0000&lt;p&gt;Erdine S.SP-34, SP-35&lt;/p&gt;\u0000&lt;p&gt;Ergisi M.PP-40&lt;/p&gt;\u0000&lt;p&gt;Ertargin M.PP-17, PP-47, PP-63&lt;/p&gt;\u0000&lt;p&gt;Esen K.PP-47&lt;/p&gt;\u0000&lt;p&gt;Eyigor C.OP-09&lt;/p&gt;\u0000&lt;p&gt;\u0000&lt;b&gt;F&lt;/b&gt;\u0000&lt;/p&gt;\u0000&lt;p&gt;Fallatah S.M.A.OP-05&lt;/p&gt;\u0000&lt;p&gt;Fernández A.PP-49&lt;/p&gt;\u0000&lt;p&gt;Ferro R.PP-51, PP-52, PP-57&lt;/p&gt;\u0000&lt;p&gt;Figueiras G.PP-02&lt;/p&gt;\u0000&lt;p&gt;Fishman M.OP-06, PP-04&lt;/p&gt;\u0000&lt;p&gt;Fonseca C.B.PP-12&lt;/p&gt;\u0000&lt;p&gt;Franco M.S.OP-13&lt;/p&gt;\u0000&lt;p&gt;\u0000&lt;b&gt;G&lt;/b&gt;\u0000&lt;/p&gt;\u0000&lt;p&gt;Gage E.PP-52&lt;/p&gt;\u0000&lt;p&gt;Gemae M.R.PP-09&lt;/p&gt;\u0000&lt;p&gt;Generoso L.POP-14","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140562733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pain Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1